
|Articles|March 1, 1996
Supplements and Featured Publications
- Calcium Channel Blockers: 1995 -- The Year in Review
- Volume 2
- Issue 4 Suppl
Calcium Channel Blockers: New Trials and Trials in Progress
Advertisement
Articles in this issue
over 29 years ago
Calcium Channel Blockers: 1995 - An Overviewover 29 years ago
Safety of Calcium Channel Blockers: Results of Recent Trialsover 29 years ago
Are Calcium Channel Blockers Prohemorrhagic?over 29 years ago
A Provocative Interpretation of the Case Control Analysisover 29 years ago
Shades of Opinion: What Is Prudent?over 29 years ago
ParticipantsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma
2
IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?
3
Guidelines for Bronchiectasis Highlight Multiple Treatment Methods
4
Belantamab Mafodotin Can Help Fill Access Gaps in BCMA-Directed Myeloma Therapy: Hearn Jay Cho, MD, PhD
5















































